$China SXT Pharmaceuticals (SXTC.US)$ Just my thoughts, no p...
$China SXT Pharmaceuticals (SXTC.US)$ Just my thoughts, no position here.
If you zoom out to the 5-year chart, this stock has a clear habit of dumping hard into the ~$0.15 area and then bouncing aggressively. The latest nosedive lines up with the offering news, which explains the selloff and heavy volume. That’s pretty typical whenever dilution hits.
An offering doesn’t mean the company is worthless. If anything, it shows they believe the product or roadmap has enough value to raise capital around it. From here, it feels like the next move comes down to whether we get confirmation the offering is done or follow-up news on their AI plans, both of which have driven moves in the past.
If you zoom out to the 5-year chart, this stock has a clear habit of dumping hard into the ~$0.15 area and then bouncing aggressively. The latest nosedive lines up with the offering news, which explains the selloff and heavy volume. That’s pretty typical whenever dilution hits.
An offering doesn’t mean the company is worthless. If anything, it shows they believe the product or roadmap has enough value to raise capital around it. From here, it feels like the next move comes down to whether we get confirmation the offering is done or follow-up news on their AI plans, both of which have driven moves in the past.
At these levels, this looks less like a trend and more like a floor-testing phase that’s played out before. No guarantees and definitely high risk, but this is the zone where this name has historically either stabilized or reversed.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Filings don’t lie, but CEOs do. 🔍 Hunting the dilution traps & toxic splits pumpers want you to ignore. Trade smart.
50
Followers
1
Following
161
Visitors
Follow